Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Standard Versus Pre-emptive Antibiotic Treatment to Reduce the Rate of Infectious Outcomes After Whipple's Procedure (SPARROW): a Multicenter, Randomized Controlled Trial

NCT05784311 is registered in ClinicalTrials.gov with Leiden University Medical Center as lead sponsor.

NCT NCT05784311
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05784311 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Standard Versus Pre-emptive Antibiotic Treatment to Reduce the Rate of Infectious Outcomes After Whipple's Procedure (SPARROW): a Multicenter, Randomized Controlled Trial
Lead sponsor
Leiden University Medical Center
Phase
Phase 4
Overall status
Recruiting
Start date
March 6, 2023
Completion date
January 31, 2026
Enrollment
344 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic cancer